The Health Care M&A Monthly: Warner Chilcott Expands
Pays $3.1 Billion For P&G’s Global Pharma Business Despite any claims you may hear to the contrary, size does matter in the Pharmaceutical industry. Whether it’s the size of your drug portfolio, market share or revenue, considerations of size and scale motivate...The Health Care M&A Monthly: Health Care Financing Activity
Today’s VC Is Tomorrow’s M&A News about health care financing activity can provide us with insight on mergers and acquisitions in the making. Companies in search of capital to develop their technologies and ideas into marketable products have a variety of...The Health Care Acquisition Report
The industry bible of mergers and acquisitions in healthcare services More than any corporate resource, The Health Care Acquisition Report is the most important tool in plotting your next strategic move. Get exclusive trend analysis on M&A in hospitals, managed...The Health Care M&A Monthly: Bristol-Myers Buys Medarex–
Pays Big Premium For Antibody Technology Toward the end of July, Bristol-Myers Squibb (NYSE: BMY) and Medarex (NASDAQ: MEDX) announced that they had agreed to a merger in which BMY would acquire MEDX and its antibody-based therapeutics platform for $2.4 billion. No...The Health Care M&A Monthly: Long-Term Care Makes A Comeback–
Higher Deal Volume Hints At End of Log-Jam During July the Long-Term Care sector posted a total of 10 deals involving 21 facilities. This marks the first time in 2009 that monthly deal volume in this sector has risen above six. We know that brokers, buyers and...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
